Certificazione DIN EN ISO 17100:2015-05 · TÜV DIN CERTCO Reg. 7U385
Membro Certificato ProZ.com Translation Network
Home › Blog e Analisi › Multilingual Clinical Trial Localization and Pharmacovigilance in Global Vaccine Rollouts

Multilingual Clinical Trial Localization and Pharmacovigilance in Global Vaccine Rollouts

Unprecedented timelines for global clinical trials and vaccine distribution in 2021 have placed life sciences translation at the center of public health—requiring rapid linguistic validation of Informed Consent Forms (ICFs) and 24/7 adverse event reporting.

Accelerating Multi-Regional Clinical Trials Without Compromising Compliance

In the first half of 2021, multinational pharmaceutical sponsors and Contract Research Organizations (CROs) have operated under compressed regulatory timelines to execute Phase III clinical trials and post-authorization safety studies across Europe, Latin America, and Asia-Pacific. Every clinical study protocol, Investigator's Brochure (IB), and patient-facing Informed Consent Form (ICF) must be translated and adapted for local Ethics Committees (IRBs/IECs) in full compliance with Good Clinical Practice (ICH E6 R2) and ISO 17100 standards.

Clinical Trial Localization Pharmacovigilance – LIFE SCIENCES
LIFE SCIENCES — Professional Localization & Regulatory Quality Assurance (April 22, 2021)

Linguistic Validation of ePROs and Real-Time Pharmacovigilance

As trials increasingly rely on electronic Patient-Reported Outcomes (ePRO) and mobile health diaries, translators must perform rigorous linguistic validation—including dual forward translation, reconciliation, back-translation, and cognitive debriefing with native patients—to ensure conceptual equivalence across cultures. Simultaneously, global pharmacovigilance teams require rapid 24-hour translation of Suspected Unexpected Serious Adverse Reactions (SUSARs) and Periodic Safety Update Reports (PSURs) coded accurately against MedDRA (Medical Dictionary for Regulatory Activities) terminology.

Executive Takeaways for Global Enterprises

  • Key Insight: Linguistic validation of Patient-Reported Outcomes (PRO/eCOA) follows strict ISPOR and FDA/EMA dual-forward and back-translation protocols.
  • Key Insight: Pharmacovigilance adverse event reporting demands rapid turnaround times and strict adherence to official MedDRA terminology.
  • Key Insight: Certified medical translators play a critical role in patient comprehension and ethical informed consent across diverse populations.

Nota Editoriale e di Garanzia della Qualità: Questo articolo di approfondimento è stato redatto dal dipartimento editoriale e di ricerca linguistica di Alphatrad Worldwide Ltd in conformità con gli standard qualitativi internazionali ISO 17100 e ISO 18587.

Riferimento Istituzionale: Alphatrad Worldwide Ltd — Ricerca Linguistica & Assicurazione Qualità

Avete bisogno di traduzioni multilingue certificate, asseverazioni legali o localizzazione conforme agli standard ISO per i vostri progetti internazionali? Richiedete un preventivo gratuito personalizzato ad Alphatrad e riceverete un piano operativo dettagliato entro 24 ore.

← Ritorna alla lettura di tutti gli articoli Richiedi un Preventivo Gratuito →